Author:
Patel Harun M.,Pawara Rahul,Surana Sanjay J.
Reference68 articles.
1. Recent progress on third generation covalent EGFR inhibitors;Cheng;Bioorg. Med. Chem. Lett.,2016
2. Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer;Wang;J. Hematol. Oncol.,2016
3. Heterocyclic Compounds and Uses Thereof, WO Patent 2012061299 A1;Baevsky,2012
4. Lung cancer: diverse EGFR mutations explain AZD9291 resistance;Thomas;Nat. Rev. Clin. Oncol.,2015
5. Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations;Avizienyte;Biochem. J.,2008
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献